ArticleJournal for immunotherapy of cancer2022

Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.

Zhuo Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.